Showing results (51-60 of 343) with videos related to
Sort By:
Pageof 35
Journal of Chromatography|February 11, 1979
Determination of L-alanosine in plasma and urine by reversed-phase high-performance liquid chromatography of the Dns derivativeG Powis, M M AmesJournal of Medicinal Chemistry|September 1, 1975
Structure-activity relationship in synthetic fibrinolytics. 2-PhenethynylcyclopropanecarboxylatesM Yoshimoto, K N von Kaulla, C HanschJournal of Medicinal Chemistry|May 1, 1981
Quantitative structure-selectivity relationships. Comparison of the inhibition of Escherichia coli and bovine liver dihydrofolate reductase by 5-(substituted-benzyl)-2,4-diaminopyrimidinesR L Li, S W Dietrich, C HanschMutation Research|November 14, 1997
QSAR treatment of multiple toxicities: the mutagenicity and cytotoxicity of quinolinesC J Smith, C Hansch, M J MortonJournal of Medicinal Chemistry|May 1, 1976
Inhibition of dihydrofolate reductase. Structure-activity correlations of quinazolinesJ Y Fukunaga, C Hansch, E E StellerJournal of Medicinal Chemistry|July 1, 1990
Structure-activity relationships of antineoplastic agents in multidrug resistanceC D Selassie, C Hansch, T A KhwajaBiochemical Pharmacology|January 1, 1982
Stereochemical aspects of para-chloroamphetamine metabolism. Rabbit liver microsomal metabolism of RS-, R(-)-. and S(+)-para-chloroamphetamineM M Ames, S K FrankCancer Chemotherapy and Pharmacology|January 1, 1995
Comparative resistance of idarubicin, doxorubicin and their C-13 alcohol metabolites in human MDR1 transfected NIH-3T3 cellsM J Kuffel, M M AmesCancer Treatment Reports|July 1, 1982
Parenteral formulation of hexamethylmelamine potentially suitable for use in manM M Ames, J S KovachMutation Research|July 1, 1992
Mutagenicity of quinolines in Salmonella typhimurium TA100. A QSAR study based on hydrophobicity and molecular orbital determinantsA K Debnath, R L de Compadre, C HanschPageof 35